Low miR‑210 and CASP8AP2 expression is associated with a poor outcome in pediatric acute lymphoblastic leukemia | Zendy

Yanyan Mei | Zendy; Zhigang Li | Zendy; Yi Zhang | Zendy; Weiling Zhang | Zendy; Huimin Hu | Zendy; Pinwei Zhang | Zendy; MinYuan Wu | Zendy; Dongsheng Huang | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Low miR‑210 and CASP8AP2 expression is associated with a poor outcome in pediatric acute lymphoblastic leukemia

Author(s) -

Yanyan Mei,

Zhigang Li,

Yi Zhang,

Weiling Zhang,

Huimin Hu,

Pinwei Zhang,

MinYuan Wu,

Dongsheng Huang

Publication year - 2017

Publication title -

oncology letters

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.766

H-Index - 54

eISSN - 1792-1082

pISSN - 1792-1074

DOI - 10.3892/ol.2017.7229

Subject(s) - oncogene , minimal residual disease , molecular medicine , microrna , real time polymerase chain reaction , polymerase chain reaction , reverse transcription polymerase chain reaction , lymphoblastic leukemia , receiver operating characteristic , oncology , medicine , cell cycle , gene , bone marrow , gene expression , cancer research , risk stratification , reverse transcriptase , biology , leukemia , cancer , genetics

The prognostic significance of microRNA (miR)-210 and the caspase 8-associated protein 2 ( CASP8AP2 ) gene in children with acute lymphoblastic leukemia (ALL) has been validated and CASP8AP2 has been demonstrated as a target of miR-210. In the present study, the reverse transcription-quantitative polymerase chain reaction (RT-qPCR) was used to determine miR-210 and CASP8AP2 expression in 91 children with ALL. Associations between gene expression levels and the prognostic value of combined detection of the two indicators were analyzed. Results from a receiver operating characteristic curve demonstrated that threshold values of miR-210 and CASP8AP2 were 3.8243 and 0.4760, respectively. Although the expression of miR-210 and CASP8AP2 were not associated at the mRNA level in pediatric ALL, combined detection of the two predicted ALL prognosis with an increased accuracy. Furthermore, an equation was devised including minimal residual disease at day 33 and expression of miR-210 and CASP8AP2 , which may enable bone marrow relapse to be predicted more precisely compared with the current risk stratification.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research